The announcement of a $150 million convertible senior notes offering by Cardlytics is likely to be viewed positively by investors, as it could provide the company with additional capital for growth or other corporate activities. This financial move is typically seen as a sign of confidence by the company in its future prospects, potentially leading to an increase in stock price in the short term.